SEC Tracker
Get the app

Longeveron LGVN

Longeveron: quarterly report for the quarter ended Sep 30, 2022

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Longeveron files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lipocine LPCN public float $16M, Jun 30, 2025
  2. Marker Therapeutics MRKR public float $17M, Jun 30, 2025
  3. CalciMedica CALC public float $16M, Jun 30, 2025
  4. Ernexa Therapeutics ERNA public float $18M, Jun 30, 2025
  5. Charlie's Holdings CHUC public float $18M, Jun 30, 2025